Kancera
  • Svenska
  • Home
  • About us
    • Statement from the CEO
    • Business model
    • Keys to success
    • History and strengths
    • Management
    • Board of directors
  • Research&Development
    • R&D portfolio
    • Fractalkine project
    • ROR inhibitors project
    • HDAC6 project
    • PFKFB3 project
  • Investors
    • The share
    • Press releases
    • Reports
      • Principles and definitions
    • Calendar
    • Corporate Governance
      • Articles of association
      • General meeting
      • Board of directors committee
      • Board of directors
      • CEO and management
      • Auditors
      • Policies and procedures
    • Subscribe
  • Press
    • Press releases
    • Images and logos
    • Subscribe
    • News
    • Press contact
  • Contact
    • Careers
Select Page
  • Svenska
  • Press releases
  • Images and logos
  • Subscribe
  • News
  • Press contact

KANCERA’S FRACTALKINE PROJECT APPEARS IN BIO BUZZ

2017-06-27

Follow this link for the full story

 

Download our reports here

Read all press releases

Check out the latest news

Click on the image to download our latest report

Kancera AB

Karolinska Institutet Science Park
Banvaktsvägen 22
SE-171 48 Solna, Sweden
Tel: +46 (0)850 12 60 80

This site uses cookies. Follow the link below for more information and our web policy:
  • Website policy
  • Svenska
Copyright 2017 Kancera AB